{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:57:02Z","timestamp":1786982222936,"version":"build-2736575974"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s12035-025-05098-8","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T04:06:28Z","timestamp":1749009988000},"page":"15055-15069","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The Effect of Metformin on Astrocytes in Parkinson\u2019s Disease: Challenges and Opportunities"],"prefix":"10.1007","volume":"62","author":[{"given":"Hayder M.","family":"Al-kuraishy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghassan M.","family":"Sulaiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hebatallah M.","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdoon A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mosleh M.","family":"Abomughaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali K.","family":"Albuhadily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"5098_CR1","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1007\/s10571-023-01350-8","volume":"43","author":"HM Al-Kuraishy","year":"2023","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Elewa YHA et al (2023) Parkinson\u2019s disease risk and hyperhomocysteinemia: the possible link. Cell Mol Neurobiol 43:2743\u20132759","journal-title":"Cell Mol Neurobiol"},{"key":"5098_CR2","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.parkreldis.2021.07.032","volume":"89","author":"DJ van Wamelen","year":"2021","unstructured":"van Wamelen DJ, Sringean J, Trivedi D et al (2021) Digital health technology for non-motor symptoms in people with Parkinson\u2019s disease: futile or future? Parkinsonism Relat Disord 89:186\u2013194. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.07.032","journal-title":"Parkinsonism Relat Disord"},{"key":"5098_CR3","doi-asserted-by":"publisher","first-page":"776847","DOI":"10.3389\/fpubh.2021.776847","volume":"9","author":"Z Ou","year":"2021","unstructured":"Ou Z, Pan J, Tang S et al (2021) Global trends in the incidence, prevalence, and years lived with disability of Parkinson\u2019s disease in 204 countries\/territories from 1990 to 2019. Front public Heal 9:776847. https:\/\/doi.org\/10.3389\/fpubh.2021.776847","journal-title":"Front public Heal"},{"key":"5098_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41531-018-0058-0","volume":"4","author":"C Marras","year":"2018","unstructured":"Marras C, Beck JC, Bower JH et al (2018) Prevalence of Parkinson\u2019s disease across North America. NPJ Park Dis 4:21. https:\/\/doi.org\/10.1038\/s41531-018-0058-0","journal-title":"NPJ Park Dis"},{"key":"5098_CR5","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.4103\/1673-5374.300980","volume":"16","author":"J Dorszewska","year":"2021","unstructured":"Dorszewska J, Kowalska M, Prendecki M et al (2021) Oxidative stress factors in Parkinson\u2019s disease. Neural Regen Res 16:1383\u20131391. https:\/\/doi.org\/10.4103\/1673-5374.300980","journal-title":"Neural Regen Res"},{"key":"5098_CR6","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/brain\/awab446","volume":"145","author":"S Smaji\u0107","year":"2022","unstructured":"Smaji\u0107 S, Prada-Medina CA, Landoulsi Z et al (2022) Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state. Brain 145:964\u2013978. https:\/\/doi.org\/10.1093\/brain\/awab446","journal-title":"Brain"},{"key":"5098_CR7","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s10787-023-01400-z","volume":"32","author":"HM Al-Kuraishy","year":"2024","unstructured":"Al-Kuraishy HM, Fahad EH, Al-Windy S et al (2024) The effects of cholesterol and statins on Parkinson\u2019s neuropathology: a narrative review. Inflammopharmacology 32:917\u2013925. https:\/\/doi.org\/10.1007\/s10787-023-01400-z","journal-title":"Inflammopharmacology"},{"key":"5098_CR8","doi-asserted-by":"publisher","first-page":"e14521","DOI":"10.1111\/cns.14521","volume":"30","author":"HM Al-Kuraishy","year":"2024","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK et al (2024) Sleep disorders cause Parkinson\u2019s disease or the reverse is true: good GABA good night. CNS Neurosci Ther 30:e14521. https:\/\/doi.org\/10.1111\/cns.14521","journal-title":"CNS Neurosci Ther"},{"key":"5098_CR9","doi-asserted-by":"publisher","first-page":"102075","DOI":"10.1016\/j.arr.2023.102075","volume":"91","author":"HM Al-Kuraishy","year":"2023","unstructured":"Al-Kuraishy HM, Jabir MS, Al-Gareeb AI, Albuhadily AK (2023) The conceivable role of prolactin hormone in Parkinson disease: the same goal but with different ways. Ageing Res Rev 91:102075","journal-title":"Ageing Res Rev"},{"key":"5098_CR10","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS, Bloem BR (2018) The emerging evidence of the Parkinson pandemic. J Parkinsons Dis 8:S3\u2013S8. https:\/\/doi.org\/10.3233\/JPD-181474","journal-title":"J Parkinsons Dis"},{"key":"5098_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40659-025-00585-7","volume":"58","author":"J Wang","year":"2025","unstructured":"Wang J, Liu M, Zhao J et al (2025) Oxidative stress and dysregulated long noncoding RNAs in the pathogenesis of Parkinson\u2019s disease. Biol Res 58:7. https:\/\/doi.org\/10.1186\/s40659-025-00585-7","journal-title":"Biol Res"},{"key":"5098_CR12","doi-asserted-by":"publisher","first-page":"115154","DOI":"10.1016\/j.chaos.2024.115154","volume":"185","author":"Z Cao","year":"2024","unstructured":"Cao Z, Du L, Zhang H et al (2024) Double-edged effect of astrocyte in the transition of physiopathological states in Parkinson\u2019s disease. Chaos, Solitons Fractals 185:115154. https:\/\/doi.org\/10.1016\/j.chaos.2024.115154","journal-title":"Chaos, Solitons Fractals"},{"key":"5098_CR13","doi-asserted-by":"crossref","unstructured":"Prajapati C, Tripathi PN, Sood S, et al. (2025) Intellectual property rights in neuroprotective biomaterials. In: Biomaterials and neurodegenerative disorders. Springer, 251\u2013269","DOI":"10.1007\/978-981-97-9959-6_10"},{"key":"5098_CR14","doi-asserted-by":"publisher","DOI":"10.1201\/9781003464648","volume-title":"Synaptic plasticity in neurodegenerative disorders","author":"S Singh","year":"2024","unstructured":"Singh S, Rai SN, Singh SK (2024) Synaptic plasticity in neurodegenerative disorders. CRC Press"},{"key":"5098_CR15","doi-asserted-by":"publisher","DOI":"10.1201\/9781032620442","volume-title":"Neurodegenerative diseases: translational models, mechanisms, and therapeutics","author":"SN Rai","year":"2024","unstructured":"Rai SN, Singh S, Singh SK (2024) Neurodegenerative diseases: translational models, mechanisms, and therapeutics. CRC Press"},{"key":"5098_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13064-020-00151-9","volume":"16","author":"NA Perez-Catalan","year":"2021","unstructured":"Perez-Catalan NA, Doe CQ, Ackerman SD (2021) The role of astrocyte-mediated plasticity in neural circuit development and function. Neural Dev 16:1. https:\/\/doi.org\/10.1186\/s13064-020-00151-9","journal-title":"Neural Dev"},{"key":"5098_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41583-022-00641-1","volume":"24","author":"AN Brandebura","year":"2023","unstructured":"Brandebura AN, Paumier A, Onur TS, Allen NJ (2023) Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders. Nat Rev Neurosci 24:23\u201339. https:\/\/doi.org\/10.1038\/s41583-022-00641-1","journal-title":"Nat Rev Neurosci"},{"key":"5098_CR18","doi-asserted-by":"publisher","unstructured":"Kim S, Pajarillo E, Nyarko-Danquah I, et al. (2023) Role of astrocytes in Parkinson\u2019s disease associated with genetic mutations and neurotoxicants. Cells 12. https:\/\/doi.org\/10.3390\/cells12040622","DOI":"10.3390\/cells12040622"},{"key":"5098_CR19","doi-asserted-by":"publisher","unstructured":"Wang T, Sun Y, Dettmer U (2023) Astrocytes in Parkinson\u2019s disease: from role to possible intervention. Cells 12. https:\/\/doi.org\/10.3390\/cells12192336","DOI":"10.3390\/cells12192336"},{"key":"5098_CR20","doi-asserted-by":"publisher","first-page":"838173","DOI":"10.3389\/fnagi.2022.838173","volume":"14","author":"M-R Du","year":"2022","unstructured":"Du M-R, Gao Q-Y, Liu C-L et al (2022) Exploring the pharmacological potential of metformin for neurodegenerative diseases. Front Aging Neurosci 14:838173. https:\/\/doi.org\/10.3389\/fnagi.2022.838173","journal-title":"Front Aging Neurosci"},{"key":"5098_CR21","doi-asserted-by":"publisher","first-page":"108173","DOI":"10.1016\/j.neuropharm.2020.108173","volume":"175","author":"Y-K Ryu","year":"2020","unstructured":"Ryu Y-K, Go J, Park H-Y et al (2020) Metformin regulates astrocyte reactivity in Parkinson\u2019s disease and normal aging. Neuropharmacology 175:108173. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108173","journal-title":"Neuropharmacology"},{"key":"5098_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12974-024-03072-0","volume":"21","author":"M Wang","year":"2024","unstructured":"Wang M, Tian T, Zhou H et al (2024) Metformin normalizes mitochondrial function to delay astrocyte senescence in a mouse model of Parkinson\u2019s disease through Mfn2-cGAS signaling. J Neuroinflammation 21:81. https:\/\/doi.org\/10.1186\/s12974-024-03072-0","journal-title":"J Neuroinflammation"},{"key":"5098_CR23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.14670\/HH-18-284","volume":"36","author":"I Bozic","year":"2021","unstructured":"Bozic I, Savic D, Lavrnja I (2021) Astrocyte phenotypes: emphasis on potential markers in neuroinflammation. Histol Histopathol 36:267\u2013290. https:\/\/doi.org\/10.14670\/HH-18-284","journal-title":"Histol Histopathol"},{"key":"5098_CR24","doi-asserted-by":"publisher","first-page":"668517","DOI":"10.3389\/fendo.2021.668517","volume":"12","author":"P Mulica","year":"2021","unstructured":"Mulica P, Gr\u00fcnewald A, Pereira SL (2021) Astrocyte-neuron metabolic crosstalk in neurodegeneration: a mitochondrial perspective. Front Endocrinol (Lausanne) 12:668517. https:\/\/doi.org\/10.3389\/fendo.2021.668517","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5098_CR25","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s12916-023-03120-1","volume":"21","author":"J Lin","year":"2023","unstructured":"Lin J, Ou R, Li C et al (2023) Plasma glial fibrillary acidic protein as a biomarker of disease progression in Parkinson\u2019s disease: a prospective cohort study. BMC Med 21:420. https:\/\/doi.org\/10.1186\/s12916-023-03120-1","journal-title":"BMC Med"},{"key":"5098_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neures.2023.02.001","volume":"197","author":"M Albini","year":"2023","unstructured":"Albini M, Krawczun-Rygmaczewska A, Cesca F (2023) Astrocytes and brain-derived neurotrophic factor (BDNF). Neurosci Res 197:42\u201351. https:\/\/doi.org\/10.1016\/j.neures.2023.02.001","journal-title":"Neurosci Res"},{"key":"5098_CR27","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s11064-022-03773-z","volume":"48","author":"L Henning","year":"2023","unstructured":"Henning L, Unichenko P, Bedner P et al (2023) Overview article astrocytes as initiators of epilepsy. Neurochem Res 48:1091\u20131099. https:\/\/doi.org\/10.1007\/s11064-022-03773-z","journal-title":"Neurochem Res"},{"key":"5098_CR28","doi-asserted-by":"publisher","first-page":"814285","DOI":"10.3389\/fphys.2022.814285","volume":"13","author":"S Wang","year":"2022","unstructured":"Wang S, Wang B, Shang D et al (2022) Ion channel dysfunction in astrocytes in neurodegenerative diseases. Front Physiol 13:814285. https:\/\/doi.org\/10.3389\/fphys.2022.814285","journal-title":"Front Physiol"},{"key":"5098_CR29","doi-asserted-by":"publisher","first-page":"114173","DOI":"10.1016\/j.expneurol.2022.114173","volume":"357","author":"C Bastian","year":"2022","unstructured":"Bastian C, Zerimech S, Nguyen H et al (2022) Aging astrocytes metabolically support aging axon function by proficiently regulating astrocyte-neuron lactate shuttle. Exp Neurol 357:114173. https:\/\/doi.org\/10.1016\/j.expneurol.2022.114173","journal-title":"Exp Neurol"},{"key":"5098_CR30","doi-asserted-by":"publisher","first-page":"662017","DOI":"10.3389\/fendo.2021.662017","volume":"12","author":"O Barca-Mayo","year":"2021","unstructured":"Barca-Mayo O, L\u00f3pez M (2021) Astrocyte clocks and glucose homeostasis. Front Endocrinol (Lausanne) 12:662017. https:\/\/doi.org\/10.3389\/fendo.2021.662017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5098_CR31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1021\/acsptsci.4c00614","volume":"8","author":"S Al-Jaf","year":"2025","unstructured":"Al-Jaf S, Soliman AY, El-Yazbi AF, Abd-Elrahman KS (2025) Unveiling the interplay: neurovascular coupling, astrocytes and g protein-coupled receptors in Alzheimer\u2019s disease. ACS Pharmacol Transl Sci 8:271\u2013285. https:\/\/doi.org\/10.1021\/acsptsci.4c00614","journal-title":"ACS Pharmacol Transl Sci"},{"key":"5098_CR32","doi-asserted-by":"publisher","unstructured":"Murat CDB, Garc\u00eda-C\u00e1ceres C (2021) Astrocyte gliotransmission in the regulation of systemic metabolism. Metabolites 11. https:\/\/doi.org\/10.3390\/metabo11110732","DOI":"10.3390\/metabo11110732"},{"key":"5098_CR33","doi-asserted-by":"publisher","first-page":"102331","DOI":"10.1016\/j.pneurobio.2022.102331","volume":"217","author":"JV Andersen","year":"2022","unstructured":"Andersen JV, Schousboe A, Verkhratsky A (2022) Astrocyte energy and neurotransmitter metabolism in Alzheimer\u2019s disease: integration of the glutamate\/GABA-glutamine cycle. Prog Neurobiol 217:102331. https:\/\/doi.org\/10.1016\/j.pneurobio.2022.102331","journal-title":"Prog Neurobiol"},{"key":"5098_CR34","doi-asserted-by":"publisher","unstructured":"Schiera G, Di Liegro CM, Schir\u00f2 G, et al. (2024) Involvement of astrocytes in the formation, maintenance, and function of the blood-brain barrier. Cells 13. https:\/\/doi.org\/10.3390\/cells13020150","DOI":"10.3390\/cells13020150"},{"key":"5098_CR35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00422-024-00994-z","volume":"118","author":"DW Garcia","year":"2024","unstructured":"Garcia DW, Jacquir S (2024) Astrocyte-mediated neuronal irregularities and dynamics: the complexity of the tripartite synapse. Biol Cybern 118:249\u2013266. https:\/\/doi.org\/10.1007\/s00422-024-00994-z","journal-title":"Biol Cybern"},{"key":"5098_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1042\/EBC20220075","volume":"67","author":"A Almeida","year":"2023","unstructured":"Almeida A, Jimenez-Blasco D, Bola\u00f1os JP (2023) Cross-talk between energy and redox metabolism in astrocyte-neuron functional cooperation. Essays Biochem 67:17\u201326. https:\/\/doi.org\/10.1042\/EBC20220075","journal-title":"Essays Biochem"},{"key":"5098_CR37","doi-asserted-by":"publisher","first-page":"780","DOI":"10.4149\/BLL_2024_119","volume":"125","author":"I Sivakova","year":"2024","unstructured":"Sivakova I, Polak S, Perzelova A (2024) Problematic visualization of human protoplasmic astrocytes immunohistochemical stains. Bratisl Lek Listy 125:780\u2013784. https:\/\/doi.org\/10.4149\/BLL_2024_119","journal-title":"Bratisl Lek Listy"},{"key":"5098_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11064-019-02926-x","volume":"46","author":"S K\u00f6hler","year":"2021","unstructured":"K\u00f6hler S, Winkler U, Hirrlinger J (2021) Heterogeneity of astrocytes in grey and white matter. Neurochem Res 46:3\u201314. https:\/\/doi.org\/10.1007\/s11064-019-02926-x","journal-title":"Neurochem Res"},{"key":"5098_CR39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/jnc.15941","volume":"167","author":"MB Cieri","year":"2023","unstructured":"Cieri MB, Villarreal A, Gomez-Cuautle DD et al (2023) Progression of reactive gliosis and astroglial phenotypic changes following stab wound-induced traumatic brain injury in mice. J Neurochem 167:183\u2013203. https:\/\/doi.org\/10.1111\/jnc.15941","journal-title":"J Neurochem"},{"key":"5098_CR40","doi-asserted-by":"publisher","first-page":"105080","DOI":"10.1016\/j.neuint.2021.105080","volume":"148","author":"Y-Y Fan","year":"2021","unstructured":"Fan Y-Y, Huo J (2021) A1\/A2 astrocytes in central nervous system injuries and diseases: angels or devils? Neurochem Int 148:105080. https:\/\/doi.org\/10.1016\/j.neuint.2021.105080","journal-title":"Neurochem Int"},{"key":"5098_CR41","doi-asserted-by":"publisher","unstructured":"Za\u0142uski M, \u0141a\u017cewska D, Ja\u015bko P, et al. (2023) Anti-inflammatory activities of 8-benzylaminoxanthines showing high adenosine A(2A) and dual A(1)\/A(2A) receptor affinity. Int J Mol Sci 24. https:\/\/doi.org\/10.3390\/ijms241813707","DOI":"10.3390\/ijms241813707"},{"key":"5098_CR42","doi-asserted-by":"publisher","first-page":"20241041","DOI":"10.1515\/med-2024-1041","volume":"19","author":"L Shao","year":"2024","unstructured":"Shao L, Wang C, Xu G et al (2024) Utilizing reactive oxygen species-scavenging nanoparticles for targeting oxidative stress in the treatment of ischemic stroke: a review. Open Med (Warsaw, Poland) 19:20241041. https:\/\/doi.org\/10.1515\/med-2024-1041","journal-title":"Open Med (Warsaw, Poland)"},{"key":"5098_CR43","doi-asserted-by":"publisher","first-page":"703810","DOI":"10.3389\/fncel.2021.703810","volume":"15","author":"AJ Moulson","year":"2021","unstructured":"Moulson AJ, Squair JW, Franklin RJM et al (2021) Diversity of reactive astrogliosis in CNS pathology: heterogeneity or plasticity? Front Cell Neurosci 15:703810. https:\/\/doi.org\/10.3389\/fncel.2021.703810","journal-title":"Front Cell Neurosci"},{"key":"5098_CR44","doi-asserted-by":"publisher","first-page":"577806","DOI":"10.1016\/j.jneuroim.2022.577806","volume":"364","author":"Q Miao","year":"2022","unstructured":"Miao Q, Chai Z, Song L-J et al (2022) The neuroprotective effects and transdifferentiation of astrocytes into dopaminergic neurons of Ginkgolide K on Parkinson\u2019 disease mice. J Neuroimmunol 364:577806. https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577806","journal-title":"J Neuroimmunol"},{"key":"5098_CR45","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/ana.21885","volume":"67","author":"M Asanuma","year":"2010","unstructured":"Asanuma M, Miyazaki I, Diaz-Corrales FJ et al (2010) Neuroprotective effects of zonisamide target astrocyte. Ann Neurol 67:239\u2013249. https:\/\/doi.org\/10.1002\/ana.21885","journal-title":"Ann Neurol"},{"key":"5098_CR46","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/01.jnen.0000195941.48033.eb","volume":"65","author":"Y Ishida","year":"2006","unstructured":"Ishida Y, Nagai A, Kobayashi S, Kim SU (2006) Upregulation of protease-activated receptor-1 in astrocytes in Parkinson disease: astrocyte-mediated neuroprotection through increased levels of glutathione peroxidase. J Neuropathol Exp Neurol 65:66\u201377. https:\/\/doi.org\/10.1097\/01.jnen.0000195941.48033.eb","journal-title":"J Neuropathol Exp Neurol"},{"key":"5098_CR47","doi-asserted-by":"publisher","first-page":"4936","DOI":"10.2174\/1381612823666170710163731","volume":"23","author":"I Miyazaki","year":"2017","unstructured":"Miyazaki I, Asanuma M (2017) Therapeutic strategy of targeting astrocytes for neuroprotection in Parkinson\u2019s disease. Curr Pharm Des 23:4936\u20134947. https:\/\/doi.org\/10.2174\/1381612823666170710163731","journal-title":"Curr Pharm Des"},{"key":"5098_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-017-0967-6","volume":"14","author":"H Patel","year":"2017","unstructured":"Patel H, McIntire J, Ryan S et al (2017) Anti-inflammatory effects of astroglial \u03b17 nicotinic acetylcholine receptors are mediated by inhibition of the NF-\u03baB pathway and activation of the Nrf2 pathway. J Neuroinflammation 14:1\u201315","journal-title":"J Neuroinflammation"},{"key":"5098_CR49","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fnagi.2020.00024","volume":"12","author":"MF Serapide","year":"2020","unstructured":"Serapide MF, L\u2019Episcopo F, Tirolo C et al (2020) Boosting antioxidant self-defenses by grafting astrocytes rejuvenates the aged microenvironment and mitigates nigrostriatal toxicity in Parkinsonian brain via an Nrf2-driven Wnt\/\u03b2-catenin prosurvival axis. Front Aging Neurosci 12:24","journal-title":"Front Aging Neurosci"},{"key":"5098_CR50","doi-asserted-by":"publisher","unstructured":"Palasz E, Wysocka A, Gasiorowska A, et al. (2020) BDNF as a promising therapeutic agent in Parkinson\u2019s disease. Int J Mol Sci 21. https:\/\/doi.org\/10.3390\/ijms21031170","DOI":"10.3390\/ijms21031170"},{"key":"5098_CR51","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3233\/JPD-202004","volume":"10","author":"RA Barker","year":"2020","unstructured":"Barker RA, Bj\u00f6rklund A, Gash DM et al (2020) GDNF and Parkinson\u2019s disease: where next? A summary from a recent workshop. J Parkinsons Dis 10:875\u2013891. https:\/\/doi.org\/10.3233\/JPD-202004","journal-title":"J Parkinsons Dis"},{"key":"5098_CR52","doi-asserted-by":"publisher","first-page":"203","DOI":"10.31083\/j.jin2311203","volume":"23","author":"O Harackiewicz","year":"2024","unstructured":"Harackiewicz O, Grembecka B (2024) The role of microglia and astrocytes in the pathomechanism of neuroinflammation in Parkinson\u2019s disease-focus on alpha-synuclein. J Integr Neurosci 23:203. https:\/\/doi.org\/10.31083\/j.jin2311203","journal-title":"J Integr Neurosci"},{"key":"5098_CR53","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/neurosci5010005","volume":"5","author":"D Brash-Arias","year":"2024","unstructured":"Brash-Arias D, Garc\u00eda LI, P\u00e9rez-Estudillo CA et al (2024) The role of astrocytes and alpha-synuclein in Parkinson\u2019s disease: a review. NeuroSci 5:71\u201386. https:\/\/doi.org\/10.3390\/neurosci5010005","journal-title":"NeuroSci"},{"key":"5098_CR54","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1007\/s12035-021-02327-8","volume":"58","author":"L Streubel-Gallasch","year":"2021","unstructured":"Streubel-Gallasch L, Giusti V, Sandre M et al (2021) Parkinson\u2019s disease-associated LRRK2 interferes with astrocyte-mediated alpha-synuclein clearance. Mol Neurobiol 58:3119\u20133140. https:\/\/doi.org\/10.1007\/s12035-021-02327-8","journal-title":"Mol Neurobiol"},{"key":"5098_CR55","doi-asserted-by":"publisher","first-page":"8618","DOI":"10.1523\/JNEUROSCI.0954-20.2020","volume":"40","author":"T Tsunemi","year":"2020","unstructured":"Tsunemi T, Ishiguro Y, Yoroisaka A et al (2020) Astrocytes protect human dopaminergic neurons from \u03b1-synuclein accumulation and propagation. J Neurosci Off J Soc Neurosci 40:8618\u20138628. https:\/\/doi.org\/10.1523\/JNEUROSCI.0954-20.2020","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"5098_CR56","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40035-021-00265-y","volume":"10","author":"C Wang","year":"2021","unstructured":"Wang C, Yang T, Liang M et al (2021) Astrocyte dysfunction in Parkinson\u2019s disease: from the perspectives of transmitted \u03b1-synuclein and genetic modulation. Transl Neurodegener 10:39. https:\/\/doi.org\/10.1186\/s40035-021-00265-y","journal-title":"Transl Neurodegener"},{"key":"5098_CR57","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1007\/s11064-011-0471-9","volume":"36","author":"RB Mythri","year":"2011","unstructured":"Mythri RB, Venkateshappa C, Harish G et al (2011) Evaluation of markers of oxidative stress, antioxidant function and astrocytic proliferation in the striatum and frontal cortex of Parkinson\u2019s disease brains. Neurochem Res 36:1452\u20131463. https:\/\/doi.org\/10.1007\/s11064-011-0471-9","journal-title":"Neurochem Res"},{"key":"5098_CR58","doi-asserted-by":"publisher","first-page":"104647","DOI":"10.1016\/j.nbd.2019.104647","volume":"134","author":"E Aflaki","year":"2020","unstructured":"Aflaki E, Stubblefield BK, McGlinchey RP et al (2020) A characterization of Gaucher iPS-derived astrocytes: potential implications for Parkinson\u2019s disease. Neurobiol Dis 134:104647. https:\/\/doi.org\/10.1016\/j.nbd.2019.104647","journal-title":"Neurobiol Dis"},{"key":"5098_CR59","doi-asserted-by":"publisher","first-page":"11835","DOI":"10.1523\/JNEUROSCI.0983-17.2017","volume":"37","author":"J Rostami","year":"2017","unstructured":"Rostami J, Holmqvist S, Lindstr\u00f6m V et al (2017) Human astrocytes transfer aggregated alpha-synuclein via tunneling nanotubes. J Neurosci Off J Soc Neurosci 37:11835\u201311853. https:\/\/doi.org\/10.1523\/JNEUROSCI.0983-17.2017","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"5098_CR60","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.toxlet.2020.06.016","volume":"331","author":"Y Meng","year":"2020","unstructured":"Meng Y, Ding J, Li C et al (2020) Transfer of pathological \u03b1-synuclein from neurons to astrocytes via exosomes causes inflammatory responses after METH exposure. Toxicol Lett 331:188\u2013199. https:\/\/doi.org\/10.1016\/j.toxlet.2020.06.016","journal-title":"Toxicol Lett"},{"key":"5098_CR61","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-018-0276-2","volume":"13","author":"C Kim","year":"2018","unstructured":"Kim C, Spencer B, Rockenstein E et al (2018) Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating \u03b1-synuclein transmission and neuroinflammation. Mol Neurodegener 13:43. https:\/\/doi.org\/10.1186\/s13024-018-0276-2","journal-title":"Mol Neurodegener"},{"key":"5098_CR62","doi-asserted-by":"publisher","first-page":"14474","DOI":"10.1038\/s41598-020-71329-8","volume":"10","author":"T-M Sonninen","year":"2020","unstructured":"Sonninen T-M, H\u00e4m\u00e4l\u00e4inen RH, Koskuvi M et al (2020) Metabolic alterations in Parkinson\u2019s disease astrocytes. Sci Rep 10:14474. https:\/\/doi.org\/10.1038\/s41598-020-71329-8","journal-title":"Sci Rep"},{"key":"5098_CR63","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12868-015-0192-0","volume":"16","author":"EH Rannikko","year":"2015","unstructured":"Rannikko EH, Weber SS, Kahle PJ (2015) Exogenous \u03b1-synuclein induces toll-like receptor 4 dependent inflammatory responses in astrocytes. BMC Neurosci 16:57. https:\/\/doi.org\/10.1186\/s12868-015-0192-0","journal-title":"BMC Neurosci"},{"key":"5098_CR64","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00401-018-1907-y","volume":"137","author":"CD Hughes","year":"2019","unstructured":"Hughes CD, Choi ML, Ryten M et al (2019) Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson\u2019s disease pathogenesis. Acta Neuropathol 137:103\u2013120. https:\/\/doi.org\/10.1007\/s00401-018-1907-y","journal-title":"Acta Neuropathol"},{"key":"5098_CR65","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1124\/mol.118.112631","volume":"94","author":"KA Popichak","year":"2018","unstructured":"Popichak KA, Hammond SL, Moreno JA et al (2018) Compensatory expression of Nur77 and Nurr1 regulates NF-\u03baB-dependent inflammatory signaling in astrocytes. Mol Pharmacol 94:1174\u20131186. https:\/\/doi.org\/10.1124\/mol.118.112631","journal-title":"Mol Pharmacol"},{"key":"5098_CR66","doi-asserted-by":"publisher","first-page":"9248","DOI":"10.1523\/JNEUROSCI.1731-12.2012","volume":"32","author":"X Lin","year":"2012","unstructured":"Lin X, Parisiadou L, Sgobio C et al (2012) Conditional expression of Parkinson\u2019s disease-related mutant \u03b1-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1. J Neurosci Off J Soc Neurosci 32:9248\u20139264. https:\/\/doi.org\/10.1523\/JNEUROSCI.1731-12.2012","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"5098_CR67","doi-asserted-by":"publisher","first-page":"8756","DOI":"10.1073\/pnas.1509742112","volume":"112","author":"C-H Kim","year":"2015","unstructured":"Kim C-H, Han B-S, Moon J et al (2015) Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson\u2019s disease. Proc Natl Acad Sci U S A 112:8756\u20138761. https:\/\/doi.org\/10.1073\/pnas.1509742112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5098_CR68","doi-asserted-by":"publisher","first-page":"E2517","DOI":"10.1073\/pnas.1502740112","volume":"112","author":"NM Urs","year":"2015","unstructured":"Urs NM, Bido S, Peterson SM et al (2015) Targeting \u03b2-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson\u2019s disease. Proc Natl Acad Sci U S A 112:E2517\u2013E2526. https:\/\/doi.org\/10.1073\/pnas.1502740112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5098_CR69","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12974-020-01776-7","volume":"17","author":"J Rostami","year":"2020","unstructured":"Rostami J, Fotaki G, Sirois J et al (2020) Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson\u2019s disease brain. J Neuroinflammation 17:119. https:\/\/doi.org\/10.1186\/s12974-020-01776-7","journal-title":"J Neuroinflammation"},{"key":"5098_CR70","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10863-019-09798-4","volume":"51","author":"LP Dolgacheva","year":"2019","unstructured":"Dolgacheva LP, Berezhnov AV, Fedotova EI et al (2019) Role of DJ-1 in the mechanism of pathogenesis of Parkinson\u2019s disease. J Bioenerg Biomembr 51:175\u2013188. https:\/\/doi.org\/10.1007\/s10863-019-09798-4","journal-title":"J Bioenerg Biomembr"},{"key":"5098_CR71","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/brain\/awh054","volume":"127","author":"R Bandopadhyay","year":"2004","unstructured":"Bandopadhyay R, Kingsbury AE, Cookson MR et al (2004) The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson\u2019s disease. Brain 127:420\u2013430. https:\/\/doi.org\/10.1093\/brain\/awh054","journal-title":"Brain"},{"key":"5098_CR72","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1096\/fj.08-125153","volume":"23","author":"J Waak","year":"2009","unstructured":"Waak J, Weber SS, Waldenmaier A et al (2009) Regulation of astrocyte inflammatory responses by the Parkinson\u2019s disease-associated gene DJ-1. FASEB J Off Publ Fed Am Soc Exp Biol 23:2478\u20132489. https:\/\/doi.org\/10.1096\/fj.08-125153","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"5098_CR73","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1002\/glia.23828","volume":"68","author":"D-J Choi","year":"2020","unstructured":"Choi D-J, Yang H, Gaire S et al (2020) Critical roles of astrocytic-CCL2-dependent monocyte infiltration in a DJ-1 knockout mouse model of delayed brain repair. Glia 68:2086\u20132101. https:\/\/doi.org\/10.1002\/glia.23828","journal-title":"Glia"},{"key":"5098_CR74","doi-asserted-by":"publisher","first-page":"101039","DOI":"10.1016\/j.arr.2020.101039","volume":"59","author":"JL Gollihue","year":"2020","unstructured":"Gollihue JL, Norris CM (2020) Astrocyte mitochondria: central players and potential therapeutic targets for neurodegenerative diseases and injury. Ageing Res Rev 59:101039. https:\/\/doi.org\/10.1016\/j.arr.2020.101039","journal-title":"Ageing Res Rev"},{"key":"5098_CR75","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12974-017-1018-z","volume":"14","author":"G Gustafsson","year":"2017","unstructured":"Gustafsson G, Lindstr\u00f6m V, Rostami J et al (2017) Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes. J Neuroinflammation 14:241. https:\/\/doi.org\/10.1186\/s12974-017-1018-z","journal-title":"J Neuroinflammation"},{"key":"5098_CR76","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.mito.2018.12.002","volume":"47","author":"KZ Kuter","year":"2019","unstructured":"Kuter KZ, Olech \u0141, Dencher NA (2019) Increased energetic demand supported by mitochondrial electron transfer chain and astrocyte assistance is essential to maintain the compensatory ability of the dopaminergic neurons in an animal model of early Parkinson\u2019s disease. Mitochondrion 47:227\u2013237. https:\/\/doi.org\/10.1016\/j.mito.2018.12.002","journal-title":"Mitochondrion"},{"key":"5098_CR77","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.bbi.2019.07.009","volume":"81","author":"Z-L Hu","year":"2019","unstructured":"Hu Z-L, Sun T, Lu M et al (2019) Kir6.1\/K-ATP channel on astrocytes protects against dopaminergic neurodegeneration in the MPTP mouse model of Parkinson\u2019s disease via promoting mitophagy. Brain Behav Immun 81:509\u2013522. https:\/\/doi.org\/10.1016\/j.bbi.2019.07.009","journal-title":"Brain Behav Immun"},{"key":"5098_CR78","doi-asserted-by":"publisher","first-page":"101284","DOI":"10.1016\/j.isci.2020.101284","volume":"23","author":"T Liang","year":"2020","unstructured":"Liang T, Qian Z-M, Mu M-D et al (2020) Brain hepcidin suppresses major pathologies in experimental parkinsonism. iScience 23:101284. https:\/\/doi.org\/10.1016\/j.isci.2020.101284","journal-title":"iScience"},{"key":"5098_CR79","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3389\/fnmol.2017.00455","volume":"10","author":"H Xu","year":"2017","unstructured":"Xu H, Wang Y, Song N et al (2017) New progress on the role of glia in iron metabolism and iron-induced degeneration of dopamine neurons in Parkinson\u2019s disease. Front Mol Neurosci 10:455. https:\/\/doi.org\/10.3389\/fnmol.2017.00455","journal-title":"Front Mol Neurosci"},{"key":"5098_CR80","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00401-017-1746-2","volume":"134","author":"F Loria","year":"2017","unstructured":"Loria F, Vargas JY, Bousset L et al (2017) \u03b1-Synuclein transfer between neurons and astrocytes indicates that astrocytes play a role in degradation rather than in spreading. Acta Neuropathol 134:789\u2013808. https:\/\/doi.org\/10.1007\/s00401-017-1746-2","journal-title":"Acta Neuropathol"},{"key":"5098_CR81","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40035-018-0143-7","volume":"8","author":"S-Z Lu","year":"2019","unstructured":"Lu S-Z, Guo Y-S, Liang P-Z et al (2019) Suppression of astrocytic autophagy by \u03b1B-crystallin contributes to \u03b1-synuclein inclusion formation. Transl Neurodegener 8:3. https:\/\/doi.org\/10.1186\/s40035-018-0143-7","journal-title":"Transl Neurodegener"},{"key":"5098_CR82","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1016\/j.neurobiolaging.2015.01.015","volume":"36","author":"Y Liu","year":"2015","unstructured":"Liu Y, Zhou Q, Tang M et al (2015) Upregulation of alphaB-crystallin expression in the substantia nigra of patients with Parkinson\u2019s disease. Neurobiol Aging 36:1686\u20131691. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.01.015","journal-title":"Neurobiol Aging"},{"key":"5098_CR83","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu Y, Zhou J (2015) Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl Neurodegener 4:19. https:\/\/doi.org\/10.1186\/s40035-015-0042-0","journal-title":"Transl Neurodegener"},{"key":"5098_CR84","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","volume":"24","author":"SP Yun","year":"2018","unstructured":"Yun SP, Kam T-I, Panicker N et al (2018) Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease. Nat Med 24:931\u2013938. https:\/\/doi.org\/10.1038\/s41591-018-0051-5","journal-title":"Nat Med"},{"key":"5098_CR85","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.neuron.2020.08.012","volume":"108","author":"M Linnerbauer","year":"2020","unstructured":"Linnerbauer M, Wheeler MA, Quintana FJ (2020) Astrocyte crosstalk in CNS inflammation. Neuron 108:608\u2013622. https:\/\/doi.org\/10.1016\/j.neuron.2020.08.012","journal-title":"Neuron"},{"key":"5098_CR86","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s10787-023-01163-7","volume":"31","author":"HM Al-Kuraishy","year":"2023","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Saad HM, Batiha GE-S (2023) Long-term use of metformin and Alzheimer\u2019s disease: beneficial or detrimental effects. Inflammopharmacology 31:1107\u20131115. https:\/\/doi.org\/10.1007\/s10787-023-01163-7","journal-title":"Inflammopharmacology"},{"key":"5098_CR87","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.5958\/0974-360X.2018.00499.7","volume":"11","author":"A Babu","year":"2018","unstructured":"Babu A, Veerasamy R, Sivadasan S (2018) Metformin-a drug of plant origin. Res J Pharm Technol 11:2701. https:\/\/doi.org\/10.5958\/0974-360X.2018.00499.7","journal-title":"Res J Pharm Technol"},{"key":"5098_CR88","doi-asserted-by":"publisher","first-page":"129241","DOI":"10.1016\/j.bmcl.2023.129241","volume":"86","author":"ED Hern\u00e1ndez-Vel\u00e1zquez","year":"2023","unstructured":"Hern\u00e1ndez-Vel\u00e1zquez ED, Alba-Betancourt C, Alonso-Castro \u00c1J et al (2023) Metformin, a biological and synthetic overview. Bioorg Med Chem Lett 86:129241. https:\/\/doi.org\/10.1016\/j.bmcl.2023.129241","journal-title":"Bioorg Med Chem Lett"},{"key":"5098_CR89","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1007\/s00125-017-4318-z","volume":"60","author":"CJ Bailey","year":"2017","unstructured":"Bailey CJ (2017) Metformin: historical overview. Diabetologia 60:1566\u20131576","journal-title":"Diabetologia"},{"key":"5098_CR90","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1177\/0885066618793385","volume":"34","author":"GS Wang","year":"2019","unstructured":"Wang GS, Hoyte C (2019) Review of Biguanide (metformin) toxicity. J Intensive Care Med 34:863\u2013876. https:\/\/doi.org\/10.1177\/0885066618793385","journal-title":"J Intensive Care Med"},{"issue":"Suppl 3","key":"5098_CR91","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/dom.15729","volume":"26","author":"A Solini","year":"2024","unstructured":"Solini A, Tric\u00f2 D (2024) Clinical efficacy and cost-effectiveness of metformin in different patient populations: a narrative review of real-world evidence. Diabetes Obes Metab 26(Suppl 3):20\u201330. https:\/\/doi.org\/10.1111\/dom.15729","journal-title":"Diabetes Obes Metab"},{"key":"5098_CR92","doi-asserted-by":"publisher","first-page":"e22243","DOI":"10.1002\/ddr.22243","volume":"85","author":"Z Al-Qahtani","year":"2024","unstructured":"Al-Qahtani Z, Al-Kuraishy HM, Ali NH et al (2024) Kynurenine pathway in type 2 diabetes: Role of metformin. Drug Dev Res 85:e22243. https:\/\/doi.org\/10.1002\/ddr.22243","journal-title":"Drug Dev Res"},{"key":"5098_CR93","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2174\/1568008033340298","volume":"3","author":"J Radziuk","year":"2003","unstructured":"Radziuk J, Bailey CJ, Wiernsperger NF, Yudkin JS (2003) Metformin and its liver targets in the treatment of type 2 diabetes. Curr Drug Targets Immune Endocr Metabol Disord 3:151\u2013169. https:\/\/doi.org\/10.2174\/1568008033340298","journal-title":"Curr Drug Targets Immune Endocr Metabol Disord"},{"key":"5098_CR94","doi-asserted-by":"publisher","first-page":"1022739","DOI":"10.3389\/fgene.2022.1022739","volume":"13","author":"S Goel","year":"2022","unstructured":"Goel S, Singh R, Singh V et al (2022) Metformin: activation of 5\u2019 AMP-activated protein kinase and its emerging potential beyond anti-hyperglycemic action. Front Genet 13:1022739. https:\/\/doi.org\/10.3389\/fgene.2022.1022739","journal-title":"Front Genet"},{"key":"5098_CR95","doi-asserted-by":"publisher","first-page":"7837","DOI":"10.1007\/s11033-022-07610-y","volume":"49","author":"F Xie","year":"2022","unstructured":"Xie F, Zhong Y, Wang D et al (2022) Metformin protects against ethanol-induced liver triglyceride accumulation by the LKB1\/AMPK\/ACC pathway. Mol Biol Rep 49:7837\u20137848. https:\/\/doi.org\/10.1007\/s11033-022-07610-y","journal-title":"Mol Biol Rep"},{"key":"5098_CR96","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1002\/hep4.1942","volume":"6","author":"S Acevedo-Acevedo","year":"2022","unstructured":"Acevedo-Acevedo S, Stefkovich ML, Kang SWS et al (2022) LKB1 acts as a critical brake for the glucagon-mediated fasting response. Hepatol Commun 6:1949\u20131961. https:\/\/doi.org\/10.1002\/hep4.1942","journal-title":"Hepatol Commun"},{"key":"5098_CR97","doi-asserted-by":"publisher","first-page":"106114","DOI":"10.1016\/j.phrs.2022.106114","volume":"177","author":"J Feng","year":"2022","unstructured":"Feng J, Wang X, Ye X et al (2022) Mitochondria as an important target of metformin: the mechanism of action, toxic and side effects, and new therapeutic applications. Pharmacol Res 177:106114. https:\/\/doi.org\/10.1016\/j.phrs.2022.106114","journal-title":"Pharmacol Res"},{"key":"5098_CR98","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s11010-023-04771-7","volume":"479","author":"M Alrouji","year":"2024","unstructured":"Alrouji M, Al-Kuraishy HM, Al-Gareeb AI et al (2024) Metformin role in Parkinson\u2019s disease: a double-sword effect. Mol Cell Biochem 479:975\u2013991. https:\/\/doi.org\/10.1007\/s11010-023-04771-7","journal-title":"Mol Cell Biochem"},{"key":"5098_CR99","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pnpbp.2017.06.002","volume":"79","author":"Y-C Kuan","year":"2017","unstructured":"Kuan Y-C, Huang K-W, Lin C-L et al (2017) Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus. Prog Neuropsychopharmacol Biol Psychiatry 79:77\u201383. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.06.002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"5098_CR100","doi-asserted-by":"publisher","first-page":"104593","DOI":"10.1016\/j.phrs.2019.104593","volume":"152","author":"YN Paudel","year":"2020","unstructured":"Paudel YN, Angelopoulou E, Piperi C et al (2020) Emerging neuroprotective effect of metformin in Parkinson\u2019s disease: a molecular crosstalk. Pharmacol Res 152:104593. https:\/\/doi.org\/10.1016\/j.phrs.2019.104593","journal-title":"Pharmacol Res"},{"key":"5098_CR101","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.neuroscience.2014.07.046","volume":"277","author":"SP Patil","year":"2014","unstructured":"Patil SP, Jain PD, Ghumatkar PJ et al (2014) Neuroprotective effect of metformin in MPTP-induced Parkinson\u2019s disease in mice. Neuroscience 277:747\u2013754. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.07.046","journal-title":"Neuroscience"},{"key":"5098_CR102","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.neuropharm.2017.08.015","volume":"125","author":"N Katila","year":"2017","unstructured":"Katila N, Bhurtel S, Shadfar S et al (2017) Metformin lowers \u03b1-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson\u2019s disease. Neuropharmacology 125:396\u2013407. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.08.015","journal-title":"Neuropharmacology"},{"key":"5098_CR103","doi-asserted-by":"publisher","first-page":"26438","DOI":"10.1073\/pnas.2009838117","volume":"117","author":"DE Mor","year":"2020","unstructured":"Mor DE, Sohrabi S, Kaletsky R et al (2020) Metformin rescues Parkinson\u2019s disease phenotypes caused by hyperactive mitochondria. Proc Natl Acad Sci U S A 117:26438\u201326447. https:\/\/doi.org\/10.1073\/pnas.2009838117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5098_CR104","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3389\/fneur.2020.00556","volume":"11","author":"C Sportelli","year":"2020","unstructured":"Sportelli C, Urso D, Jenner P, Chaudhuri KR (2020) Metformin as a potential neuroprotective agent in prodromal Parkinson\u2019s disease-viewpoint. Front Neurol 11:556. https:\/\/doi.org\/10.3389\/fneur.2020.00556","journal-title":"Front Neurol"},{"key":"5098_CR105","doi-asserted-by":"publisher","unstructured":"Huang K-H, Chang Y-L, Gau S-Y, et al. (2022) Dose-response association of metformin with Parkinson\u2019s disease odds in type 2 diabetes mellitus. Pharmaceutics 14. https:\/\/doi.org\/10.3390\/pharmaceutics14050946","DOI":"10.3390\/pharmaceutics14050946"},{"key":"5098_CR106","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.parkreldis.2012.03.010","volume":"18","author":"ML Wahlqvist","year":"2012","unstructured":"Wahlqvist ML, Lee M-S, Hsu C-C et al (2012) Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson\u2019s disease occurring with type 2 diabetes in a Taiwanese population cohort. Parkinsonism Relat Disord 18:753\u2013758. https:\/\/doi.org\/10.1016\/j.parkreldis.2012.03.010","journal-title":"Parkinsonism Relat Disord"},{"key":"5098_CR107","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.clnesp.2024.02.018","volume":"60","author":"G Pezzoli","year":"2024","unstructured":"Pezzoli G, Cereda E, Calandrella D et al (2024) Metformin use is associated with reduced mortality risk in diabetic patients with Parkinson\u2019s disease. Clin Nutr ESPEN 60:309\u2013312. https:\/\/doi.org\/10.1016\/j.clnesp.2024.02.018","journal-title":"Clin Nutr ESPEN"},{"key":"5098_CR108","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1134\/S000629792207001X","volume":"87","author":"VO Gorbatenko","year":"2022","unstructured":"Gorbatenko VO, Goriainov SV, Babenko VA et al (2022) Anti-inflammatory properties of metformin during cultivation of primary rat astrocytes in a medium with high glucose concentration. Biochemistry (Mosc) 87:577\u2013589. https:\/\/doi.org\/10.1134\/S000629792207001X","journal-title":"Biochemistry (Mosc)"},{"key":"5098_CR109","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.biochi.2024.04.005","volume":"223","author":"LD Bobermin","year":"2024","unstructured":"Bobermin LD, da Costa DS, de Moraes ADM et al (2024) Effect of metformin in hypothalamic astrocytes from an immunocompromised mice model. Biochimie 223:196\u2013205. https:\/\/doi.org\/10.1016\/j.biochi.2024.04.005","journal-title":"Biochimie"},{"key":"5098_CR110","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s11064-015-1733-8","volume":"42","author":"A Westhaus","year":"2017","unstructured":"Westhaus A, Blumrich EM, Dringen R (2017) The antidiabetic drug metformin stimulates glycolytic lactate production in cultured primary rat astrocytes. Neurochem Res 42:294\u2013305. https:\/\/doi.org\/10.1007\/s11064-015-1733-8","journal-title":"Neurochem Res"},{"key":"5098_CR111","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1002\/jnr.24050","volume":"95","author":"MC Hohnholt","year":"2017","unstructured":"Hohnholt MC, Blumrich E-M, Waagepetersen HS, Dringen R (2017) The antidiabetic drug metformin decreases mitochondrial respiration and tricarboxylic acid cycle activity in cultured primary rat astrocytes. J Neurosci Res 95:2307\u20132320. https:\/\/doi.org\/10.1002\/jnr.24050","journal-title":"J Neurosci Res"},{"issue":"12","key":"5098_CR112","doi-asserted-by":"publisher","first-page":"6568","DOI":"10.3390\/ijms22126568","volume":"22","author":"S Takahashi","year":"2021","unstructured":"Takahashi S (2021) Neuroprotective function of high glycolytic activity in astrocytes: common roles in stroke and neurodegenerative diseases. Int J Mol Sci 22(12):6568. https:\/\/doi.org\/10.3390\/ijms22126568","journal-title":"Int J Mol Sci"},{"key":"5098_CR113","doi-asserted-by":"publisher","first-page":"737304","DOI":"10.3389\/fcell.2021.737304","volume":"9","author":"A Chen","year":"2021","unstructured":"Chen A, Kristiansen CK, Hong Y et al (2021) Nicotinamide riboside and metformin ameliorate mitophagy defect in induced pluripotent stem cell-derived astrocytes with POLG mutations. Front cell Dev Biol 9:737304. https:\/\/doi.org\/10.3389\/fcell.2021.737304","journal-title":"Front cell Dev Biol"},{"key":"5098_CR114","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.bbrc.2020.10.075","volume":"534","author":"G Wang","year":"2021","unstructured":"Wang G, Cui W, Chen S et al (2021) Metformin alleviates high glucose-induced ER stress and inflammation by inhibiting the interaction between caveolin1 and AMPK\u03b1 in rat astrocytes. Biochem Biophys Res Commun 534:908\u2013913. https:\/\/doi.org\/10.1016\/j.bbrc.2020.10.075","journal-title":"Biochem Biophys Res Commun"},{"key":"5098_CR115","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13041-021-00834-2","volume":"14","author":"T-Y Ha","year":"2021","unstructured":"Ha T-Y, Choi YR, Noh HR et al (2021) Age-related increase in caveolin-1 expression facilitates cell-to-cell transmission of \u03b1-synuclein in neurons. Mol Brain 14:122. https:\/\/doi.org\/10.1186\/s13041-021-00834-2","journal-title":"Mol Brain"},{"key":"5098_CR116","doi-asserted-by":"publisher","first-page":"328","DOI":"10.5114\/fn.2018.80866","volume":"56","author":"B Gabryel","year":"2018","unstructured":"Gabryel B, Liber S (2018) Metformin limits apoptosis in primary rat cortical astrocytes subjected to oxygen and glucose deprivation. Folia Neuropathol 56:328\u2013336. https:\/\/doi.org\/10.5114\/fn.2018.80866","journal-title":"Folia Neuropathol"},{"key":"5098_CR117","doi-asserted-by":"publisher","first-page":"e12781","DOI":"10.1111\/cpr.12781","volume":"53","author":"Y Chen","year":"2020","unstructured":"Chen Y, Qin C, Huang J et al (2020) The role of astrocytes in oxidative stress of central nervous system: a mixed blessing. Cell Prolif 53:e12781. https:\/\/doi.org\/10.1111\/cpr.12781","journal-title":"Cell Prolif"},{"key":"5098_CR118","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1152\/physrev.00041.2013","volume":"94","author":"M Pekny","year":"2014","unstructured":"Pekny M, Pekna M (2014) Astrocyte reactivity and reactive astrogliosis: costs and benefits. Physiol Rev 94:1077\u20131098. https:\/\/doi.org\/10.1152\/physrev.00041.2013","journal-title":"Physiol Rev"},{"key":"5098_CR119","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fncel.2014.00216","volume":"8","author":"S Alfonso-Loeches","year":"2014","unstructured":"Alfonso-Loeches S, Ure\u00f1a-Peralta JR, Morillo-Bargues MJ et al (2014) Role of mitochondria ROS generation in ethanol-induced NLRP3 inflammasome activation and cell death in astroglial cells. Front Cell Neurosci 8:216. https:\/\/doi.org\/10.3389\/fncel.2014.00216","journal-title":"Front Cell Neurosci"},{"key":"5098_CR120","doi-asserted-by":"publisher","first-page":"796616","DOI":"10.3389\/fphar.2022.796616","volume":"13","author":"L Jin","year":"2022","unstructured":"Jin L, Jin F, Guo S et al (2022) Metformin inhibits NLR family pyrin domain containing 3 (NLRP)-relevant neuroinflammation via an adenosine-5\u2019-monophosphate-activated protein kinase (AMPK)-dependent pathway to alleviate early brain injury after subarachnoid hemorrhage in mice. Front Pharmacol 13:796616. https:\/\/doi.org\/10.3389\/fphar.2022.796616","journal-title":"Front Pharmacol"},{"key":"5098_CR121","doi-asserted-by":"publisher","unstructured":"Mahmoud S, Gharagozloo M, Simard C, Gris D (2019) Astrocytes maintain glutamate homeostasis in the CNS by Controlling the balance between glutamate uptake and release. Cells 8. https:\/\/doi.org\/10.3390\/cells8020184","DOI":"10.3390\/cells8020184"},{"key":"5098_CR122","doi-asserted-by":"publisher","first-page":"1247276","DOI":"10.1155\/2019\/1247276","volume":"2019","author":"L Wei","year":"2019","unstructured":"Wei L, Chen C, Ding L et al (2019) Wnt1 promotes EAAT2 expression and mediates the protective effects of astrocytes on dopaminergic cells in Parkinson\u2019s disease. Neural Plast 2019:1247276. https:\/\/doi.org\/10.1155\/2019\/1247276","journal-title":"Neural Plast"},{"key":"5098_CR123","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jphs.2020.07.011","volume":"144","author":"L Iovino","year":"2020","unstructured":"Iovino L, Tremblay ME, Civiero L (2020) Glutamate-induced excitotoxicity in Parkinson\u2019s disease: the role of glial cells. J Pharmacol Sci 144:151\u2013164. https:\/\/doi.org\/10.1016\/j.jphs.2020.07.011","journal-title":"J Pharmacol Sci"},{"key":"5098_CR124","doi-asserted-by":"publisher","unstructured":"Li N, Zhou T, Fei E (2022) Actions of metformin in the brain: a new perspective of metformin treatments in related neurological disorders. Int J Mol Sci 23:. https:\/\/doi.org\/10.3390\/ijms23158281","DOI":"10.3390\/ijms23158281"},{"key":"5098_CR125","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.brainresbull.2016.02.009","volume":"121","author":"C Zhou","year":"2016","unstructured":"Zhou C, Sun R, Zhuang S et al (2016) Metformin prevents cerebellar granule neurons against glutamate-induced neurotoxicity. Brain Res Bull 121:241\u2013245. https:\/\/doi.org\/10.1016\/j.brainresbull.2016.02.009","journal-title":"Brain Res Bull"},{"key":"5098_CR126","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/jnc.12511","volume":"128","author":"KK Thumburu","year":"2014","unstructured":"Thumburu KK, Dhiman RK, Vasishta RK et al (2014) Expression of astrocytic genes coding for proteins implicated in neural excitation and brain edema is altered after acute liver failure. J Neurochem 128:617\u2013627. https:\/\/doi.org\/10.1111\/jnc.12511","journal-title":"J Neurochem"},{"key":"5098_CR127","doi-asserted-by":"publisher","first-page":"112","DOI":"10.2174\/157015910791233150","volume":"8","author":"E Foglio","year":"2010","unstructured":"Foglio E, Rodella LF (2010) Aquaporins and neurodegenerative diseases. Curr Neuropharmacol 8:112\u2013121. https:\/\/doi.org\/10.2174\/157015910791233150","journal-title":"Curr Neuropharmacol"},{"key":"5098_CR128","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/WNR.0000000000001880","volume":"34","author":"C Xu","year":"2023","unstructured":"Xu C, Wang F, Su C et al (2023) Restoration of aquaporin-4 polarization in the spinal glymphatic system by metformin in rats with painful diabetic neuropathy. NeuroReport 34:190\u2013197. https:\/\/doi.org\/10.1097\/WNR.0000000000001880","journal-title":"NeuroReport"},{"key":"5098_CR129","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/syn.21941","volume":"70","author":"E Del-Bel","year":"2016","unstructured":"Del-Bel E, Bortolanza M, Dos-Santos-Pereira M et al (2016) l-DOPA-induced dyskinesia in Parkinson\u2019s disease: are neuroinflammation and astrocytes key elements? Synapse 70:479\u2013500","journal-title":"Synapse"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05098-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05098-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05098-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:31:11Z","timestamp":1759995071000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05098-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":129,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["5098"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05098-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"30 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"None declared.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"None declared.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}